These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 32503639

  • 1. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y, Liu H, He Y, Xu W, Ma Q, He Y, Lei W, Chen G, He Z, Huang J, Liu J, Liu Y, Huang Q, Yu F.
    Hum Genomics; 2020 Jun 05; 14(1):21. PubMed ID: 32503639
    [Abstract] [Full Text] [Related]

  • 2. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y, Wang R, Xi M, Wei L, Zhu W, Liu Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug 10; 40(8):933-938. PubMed ID: 37532491
    [Abstract] [Full Text] [Related]

  • 3. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M, Lindsay C, Blais J, Nshimyumukiza L, Takwoingi Y, Langlois S, Légaré F, Giguère Y, Turgeon AF, Witteman W, Rousseau F.
    Cochrane Database Syst Rev; 2017 Nov 10; 11(11):CD011767. PubMed ID: 29125628
    [Abstract] [Full Text] [Related]

  • 4. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
    Mesoraca A, Margiotti K, Dello Russo C, Cesta A, Cima A, Longo SA, Barone MA, Viola A, Sparacino D, Giorlandino C.
    Genet Res (Camb); 2020 Jun 16; 102():e5. PubMed ID: 32539871
    [Abstract] [Full Text] [Related]

  • 5. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M, De Falco L, Torella A, Savarese G, Savarese P, Ruggiero R, Conte A, Fico V, Torella M, Fico A.
    BMC Med Genomics; 2021 Mar 30; 14(1):93. PubMed ID: 33785045
    [Abstract] [Full Text] [Related]

  • 6. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB, Rode L, Ekelund CK, Sundberg K, Kjaergaard S, Zingenberg H, Tabor A.
    Ultrasound Obstet Gynecol; 2018 Apr 30; 51(4):470-479. PubMed ID: 28640470
    [Abstract] [Full Text] [Related]

  • 7. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, de Die-Smulders CEM, Duin LK, Faas BHW, Feenstra I, Haak MC, Hoffer MJV, den Hollander NS, Hollink IHIM, Jehee FS, Knapen MFCM, Kooper AJA, van Langen IM, Lichtenbelt KD, Linskens IH, van Maarle MC, Oepkes D, Pieters MJ, Schuring-Blom GH, Sikkel E, Sikkema-Raddatz B, Smeets DFCM, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Ven AJEM, van Zelderen-Bhola SL, Henneman L, Galjaard RH, Van Opstal D, Weiss MM, Dutch NIPT Consortium.
    Am J Hum Genet; 2019 Dec 05; 105(6):1091-1101. PubMed ID: 31708118
    [Abstract] [Full Text] [Related]

  • 8. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
    Li Z, Duan H, Liu W, Zhu R, Li J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan 10; 41(1):1-7. PubMed ID: 38171551
    [Abstract] [Full Text] [Related]

  • 9. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U, Chaubey A, Shenoy S, Wong YW, Chan LY, Choo BP, Oraha L, Gousseva A, Persson F, Prensky L, Chin E, Hegde M.
    Curr Issues Mol Biol; 2021 Aug 17; 43(2):958-964. PubMed ID: 34449543
    [Abstract] [Full Text] [Related]

  • 10. Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
    Scott F, Smet ME, Elhindi J, Mogra R, Sunderland L, Ferreira A, Menezes M, Meagher S, McLennan A.
    Ultrasound Obstet Gynecol; 2023 Oct 17; 62(4):497-503. PubMed ID: 37247395
    [Abstract] [Full Text] [Related]

  • 11. The accuracy and feasibility of noninvasive prenatal testing in a consecutive series of 20,626 pregnancies with different clinical characteristics.
    Zheng Y, Li J, Zhang J, Yang H.
    J Clin Lab Anal; 2022 Oct 17; 36(10):e24660. PubMed ID: 36099005
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W, Ru L, Qiuxia Y, Dan W, Xiuhong S, Yongling Z, Xiangyi J, Fatao L, Xuewei T, Guilan C, Fan J, Fucheng L, Fang F, Yan L, Lina Z, Cuixing Y, Jian L, Dongzhi L, Can L.
    Prenat Diagn; 2021 May 17; 41(6):690-696. PubMed ID: 33480032
    [Abstract] [Full Text] [Related]

  • 13. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE, Kim H, Park J, Yun T, Park DY, Kim M, Ryu HM.
    J Korean Med Sci; 2019 Jun 24; 34(24):e172. PubMed ID: 31222985
    [Abstract] [Full Text] [Related]

  • 14. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario .
    Ont Health Technol Assess Ser; 2019 Jun 24; 19(4):1-166. PubMed ID: 30847010
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.
    Liu S, Chang Q, Yang F, Xu Y, Jia B, Wu R, Li L, Yin A, Chen W, Huang F, Yang X, Li F.
    Arch Gynecol Obstet; 2023 Sep 24; 308(3):787-795. PubMed ID: 36602559
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
    Hu H, Wang L, Wu J, Zhou P, Fu J, Sun J, Cai W, Liu H, Yang Y.
    Hum Genomics; 2019 Mar 12; 13(1):14. PubMed ID: 30871627
    [Abstract] [Full Text] [Related]

  • 17. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct 10; 37(10):1065-1068. PubMed ID: 32924102
    [Abstract] [Full Text] [Related]

  • 18. Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies.
    Xue Y, Zhao G, Li H, Zhang Q, Lu J, Yu B, Wang T.
    Mol Cytogenet; 2019 Oct 10; 12():29. PubMed ID: 31249627
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of the factors influencing positive predictive value of noninvasive prenatal testing for chromosome aneuploidies].
    Zhao GY, Dai P, Hu S, Jiao ZH, Kong XD.
    Zhonghua Yi Xue Za Zhi; 2022 Aug 23; 102(31):2452-2457. PubMed ID: 36000375
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S, Xu H, Uerpairojkit B, Chen F, Charoenvidhya D, Liu H, Petcharaburanin N, Liu Y, Tang S, Wang X, Dansakul S, Thomsopa T, Gao Y, Zhang H, Xu H, Jiang H.
    Prenat Diagn; 2016 Mar 23; 36(3):224-31. PubMed ID: 26748603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.